Hopper I, Skiba M, von Lueder TG, Watanabe M, Funston R, Tonkin A, Krum H. Digoxin Withdrawal Worsens Clinical Status in Stable Patients With Heart Failure Receiving Optimal Contemporaneous Therapy-A Randomized Controlled Trial.  J Card Fail. 2015 Sep;21(9):779-81.

Girerd N, Collier T, Pocock S, Krum H, McMurray JJ, Swedberg K, Van Veldhuisen DJ, Vincent J, Pitt B, Zannad F.  Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial.  Eur Heart J. 2015 Sep 7;36(34):2310-7.

Gorcsan J 3rd, Sogaard P, Bax JJ, Singh JP, Abraham WT, Borer JS, Dickstein K, Gras D, Krum H, Brugada J, Robertson M, Ford I, Holzmeister J, Ruschitzka F. Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial.  Eur Heart J 2015 Aug 30 [Epub ahead of print] Review

Perin EC, Borow KM, Silva GV, DeMaria AN, Marroquin OC, Huang PP, Traverse JH, Krum H, Skerrett D, Zheng Y, Willerson JT, Itescu S, Henry TD.  A phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure.  Circ Res. 2015 Aug 28;117(6):576-84.

Steffel J, Robertson M, Singh JP, Abraham WT, Bax JJ, Borer JS, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J, Brugada J, Ruschitzka F.  The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial.  Eur Heart J 2015 Aug 7;36(30):1983-89.

Krum H, Hopper I. The ongoing evolution of optimal clinical endpoints for heart failure trials.  JACC Heart Fail 2015 Aug;3(8):615-7.

Polhemus DJ, Li Z, Pattillo CB, Goodchild TT, Gojon G Sr, Cojon G Jr, Giordano T, Krum H. A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients.  Cardiovasc Ther 2015 Aug;33(4):216-26.

Cannon JA, Collier TJ, Shen L, Swedberg K, Krum H, Van Veldhuisen DJ, Vincent J, Pocock SJ, Pitt B, Zannad F, McMurray JJ. Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail. 2015 Jul;17(7):707-16.

Chowdhury EK, Langham RG, Ademi Z, Owen A, Krum H, Wing LM, Nelson MR, Reid CM; Second Australian National Blood Pressure Study Management Committee. Rate of change in renal function and mortality in elderly treated hypertensive patients.  Clin J Am Soc Nephrol 2015 Jul 7;10(7):1154-61.

Starling RC, Krum H, Bril S, Tsintzos SI, Rogers T, Hudnall JH, Martin DO.  Impact of a novel adaptive optimization algorithm on 30-day readmissions: Evidence from the Adaptive CRT Trial. JACC Heart Fail 2015 Jul;3(7):565-72.

Eikelis N, Hering D, Marusic P, Sari C, Walton A, Phillips S, Lambert E, Duval J, Krum H, Lambert G, Esler M, Schlaich M.  The effect of renal denervation on endothelial function and inflammatory markers in patients with resistant hypertension.  Int J Cardiol 2015 Jun 1;188:96-98.

Gilbert RE, Krum H.  Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.  Lancet 2015 May 23;385(9982):2107-17. Review.

Wang BH, von Lueder TG, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H. Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.  Int J Cardiol 2015 May 1;186:104-105.

Rana I, Kompa AR, Skommer J, Wang BH, Lekawanvijit S, Kelly DJ, Krum H, Charchar FJ.  Contributions of microRNA to pathological fibrosis in cardiorenal syndrome: impact of uremic toxins.  Physiol Rep 2015 Apr;3(4) e12371.

Chang S, Davidson PM, Newton PJ, Macdonald P, Carrington MJ, Marwick TH, Horowitz JD, Krum H, Reid CM, Chan YK, Scuffham PA, Sibbritt D, Stewart S; WHICH Investigators. Composite outcome measures in a pragmatic clinical trial of chronic heart failure management: A comparative assessment.  Int J Cardiol 2015 Apr 15;185:62-68.

Vinh NB, Devine SM, Munoz L, Ryan RM, Wang BH, Krum H, Chalmers DK, Simpson JS, Scammells PJ.  Design, synthesis, and biological evaluation of tetra-substituted thiophenes as inhibitors of p38a MAPK.  Chemistry Open 2015 Feb;4(1):56-64.

Chowdhury EK, Langham RG, Owen A, Krum H, Wing LM, Nelson MR, Reid CM; on behalf of the Second Australian National Blood Pressure Study Management Committee.  Comparison of predictive performance of renal function estimation equations for all-cause and cardiovascular mortality in an elderly hypertensive population.  Am J Hypertens 2015 Mar;28(3):380-6.

Lekawanvijit S, Krum H.  Cardiorenal syndrome: Role of protein-bound uremic toxins. J Ren Nutr 2015 Mar;25(2):149-154.

Metra M, Cotter G, El-Khorazaty J, Davison BA, Milo O, Carubelli V, Bourge RC, Cleland JG, Jondeau G, Krum H, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Rainisio M, Kobrin I, McMurray JJ, Teerlink JR.  Acute Heart Failure in the Elderly: Differences in Clinical Characteristics, Outcomes, and Prognostic Factors in the VERITAS Study.  J Card Fail 2015 Mar;21(3):179-88.

Roberts MA, Pilmore HL, Ierino FL, Badve SV, Cass A, Garg AX, Hawley CM, Isbel NM, Krum H, Pascoe EM, Tonkin AM, Vergara LA, Perkovic V; BLOCADE study collaborative group.  The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility study.  Nephrology (Carlton). 2015 Mar;20(3):140-7.

Pitt B, Anker SD, Böhm M, Gheorghiade M, Køber L, Krum H, Maggioni AP, Ponikowski P, Voors AA, Zannad F, Nowack C, Kim SY, Pieper A, Kimmeskamp-Kirschbaum N, Filippatos G. Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease. Eur J Heart Fail 2015; Feb;17(2):224-32.

Patel HC, Hayward C, Ozdemir BA, Rosen SD, Krum H, Lyon AR, Francis DP, di Mario C.  Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation.  Hypertension 2015 Feb;65(2):401-406.

Bodey F, Hopper I, Krum H.  Neprilysin inhibitors preserve renal function in heart failure.  Int J Cardiol 2015 Jan 20;179:329-30.

Von Lueder TG, Wang BH, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H. The angiotensin-receptor neprilysin inhibitor LCZ696 attenuates cardiac remodelling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.  Circ Heart Fail 2015;Jan 8(1):71-78.

Krum H.  Prospective comparison of ARNi with ACE-I to determine impact on global mortality and morbidity in heart failure (PARADIGM-HF): Paragon of a study or further investigation paramount?  Circulation 2015 Jan 6;131(1):11-12.

Narayan O, Davies JE, Hughes AD, Dart AM, Parker KH, Reid C, Cameron JD. Central Aortic Reservoir-Wave Analysis Improves Prediction of Cardiovascular Events in Elderly Hypertensives. Hypertension 2015, Mar; 65(3):629-35.

Harding JL, Shaw JE, Anstey KA, Adams R, Balkau B, Brennan-Olsen SL, Briffa T, Davis TME, Davis WA, Dobson A, Flicker L, Giles G, Grant J, Huxley R, Knuiman M, Luszcz M, MacInnis RJ, Mitchell P, Pasco JA, Reid CM, Simmons DM, Simons L, Tonkin A, Woodward M, Peeters A & Magliano DJ.  Comparison of anthropometric measures as predictors of cancer incidence: a pooled collaborative analysis of 11 Australian cohorts Int J Cancer 2015:Oct 1;137(7):1699-708.

Meller B, Cullen L, Parsonage WA, Greenslade JH, Aldous S, Reichlin T, Wildi K, Twerenbold R, Jaeger C, Hillinger P, Haaf P, Puelacher C, Kern V, Rentsch K, Stallone F, Rubini Gimenez M, Ballarino P, Bassetti S, Walukiewicz A, Troughton R, Pemberton CJ, Richards AM, Chu K, Reid CM, Than M, Mueller C. Accelerated diagnostic protocol using high-sensitivity cardiac troponin T in acute chest pain patients.  International Journal of Cardiology April 1;184:208-15.

Chowdhury EK, Ademi Z, Moss J, Wing LMH and Reid CM on behalf of the Second Australian National Blood Pressure Study Management Committee. Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity.   Medicine 2015 Mar;94(9).

Ruwanpathirana T, Owen A, Reid CM. Review on cardiovascular risk prediction.  Cardiovascular Therapeutics 2015 April 33(2):62-70.

McQuilten ZK, Andrianopoulos N, van de Watering L, Aubron C, Phillips L, Bellomo R, Pilcher D, Cameron P, Reid CM, Cole-Sinclair MF, Newcomb A, Smith J, McNeil JJ, Wood EM.  Introduction of universal prestorage leukodepletion of blood components, and outcomes in transfused cardiac surgery patients. J Thorac Cardiovasc Surg2015 Jul;150(1):216-22.

Ruwanpathirana T, Owen A, Renzaho AM, Zomer E, Gambhir M, Reid CM. Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling. Clin Exp Pharmacol Physiol. 2015 Jun;42(6):596-601.

Dhurandhar V, Saxena A, Parikh R, Vallely MP, Wilson MK, Butcher JK, Black DA, Tran L, Reid CM, Bannon PG. Outcomes of on-pump versus off-pump coronary artery bypass graft surgery in the high risk (AusSCORE > 5). Heart Lung Circulation. 2015 Feb 23.

Couper LT, Loane P, Andrianopoulos N, Brennan A, Nanayakkara S, Nerlekar N, Scott P, Walton AS, Clark DJ, Duffy SJ. Ajani AE, Reid C, Shaw JA; Melbourne Interventional Group (MIG) Investigators.  Utility of rotational atherectomy and outcomes over an eight-year period.  Catheter Cardiovasc Interv. 2015 Jul 8.

Lim HS, Andrianopoulos N, Sugumar H, Stub D, Brennan AL, Lim CC, Barlis P, Van Gaal W, Reid CM, Charter K, Sebastian M, New G, Ajani AE, Farouque O, Duffy SJ, Clark DJ, Melbourne Interventional Group.  Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock.  Int J Cardiol. 2015 Sep 15,195:259-64.

Harding J, Sooriyakumaran M, Anstey KJ, Adams R, Balkau B, Briffa T, Davis TM, Davis WA, Dobson A, Giles GG, Grant J, Knuiman M, Luszcz M, Mitchell P, Pasco JA, Reid C, Simmons D, Simons L, Tonkin A, Woodward M, Shaw JE, Magliano DJ.  The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?  Diabetes Metab. 2015 May 30.

Ch'ng SL, Cochrane AD, Wolfe R, Reid C, Smith CI, Smith JA.  Procedure-specific cardiac surgeon volume associated with patient outcome following valve surgery, but not isolated CABG surgery. Heart Lung Circ. 2015 Jun;2(6):583-9.

Thawornchaisit P, de Looze F, Reid CM, Seubsman S, Tran TT, Sleigh A & the Thai Cohort Study Team. Health-Risk Factors and the Prevalence of Chronic Kidney Disease: Cross-Sectional Findings from a National Cohort of 87 143 Thai Open University Students. Glob J Health Sci 2015 Feb 24;7(5):42289.

Perera ML, Neiraja G, Roberts M, N, Giles M, Liew D, Ritchie P, Chan STF. The ‘Four-Hour Target’ and the impact on Australian metropolitan acute surgical services. ANZ J Surg. 2015 Jun 10. doi: 10.1111/ans.13186.

Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Leach S, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits SL, Florin TH, Gibson PR, Debinski H, Macrae FA, Samuel D, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Day AS, Desmond PV, Gearry RB. Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery. Gastroenterology. 2015 Jan 22. pii: S0016-5085(15)00111-0. doi: 10.1053/j.gastro.2015.01.026.

Cotta MO, Robertson MS, Marshall C, Thursky KA, Liew D, Buising KL. Implementing antimicrobial stewardship in the Australian private hospital system: a qualitative study. Aust Health Rev. 2015 Jan 5. doi: 10.1071/AH14111.


Wlodarczyk J, Ajani AE, Kemp D, Andrianopoulos N, Brennan AL, Duffy SJ,  Clark DJ, Reid CM. Incidence, Predictors and Outcomes of Major Bleeding in Patients Following Percutaneous Coronary Interventions in Australia.Heart, Lung & Circulation 2016, 25(2):107-117.

Karim MN, Reid CM, Cochrane A, Tran L, Billah B. When is Urgent really urgent and does it matter? Misclassification of procedural status and Implications for risk assessment in Cardiac Surgery. Heart Lung & Circulation 2016;25(2):196-203; doi:10.1016/j.hlc2015.07.003.

Lowthian JA, Britt CJ, Rance G, Linc FR, Woods RL, Wolfe R, Nelson MR, Dillon HA, Ward S, Reid CM, Lockery JE, Nguyen TT, McNeil JJ, Storey E on behalf of the ASPREE Investigators. Slowing the progression of age-related hearing loss: Rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neuro-cognition in older generations (ASPREE-HEARING) trial. Contemporary Clinical Trials, 2016: 46; 60–66d.

Harding JL, Sooriyakumaran M, Anstey KJ, Adams R, Balkau B, Briffa T, Davis TME, Davis WA, Dobson A, Giles GG, Grant J, Huxley R, Knuiman M, Luszcz M, Mitchell P, Pasco JA, Reid CM, Simmons D, Simons L, Tonkin A, Woodward M, Shaw JE & Magliano DJ.  Hypertension, anti-hypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 16 Australian and New Zealand cohorts.  J. Hypertension, 2015; 34(1):149-155.

Ariyaratne TV, Yap C-H,Ademi Z, Rosenfeldt F, Duffy SJ, Billah B, Reid CM. A Systematic Review of Cost-Effectiveness of Percutaneous Coronary Intervention versus Surgery for the Treatment of Multi-vessel Coronary Artery Disease in the Drug-Eluting Stent Era. European Heart Journal - Quality of Care and Clinical Outcomes, 2016  

Reid CM and Owen A. The Epidemiology of Cardiovascular Disease.
In; Alvaregna M & Byrne D (Eds): Handbook of Psychocardiology. 2016

Newton PJ, Davidson PM, Reid CM, Krum H, Hayward C, Sibbritt DW, Banks E, MacDonald PS on behalf of the NSW Heart Failure Snapshot Investigators. Acute heart failure admissions in New South Wales and the Australian Capital Territory: the NSW HF Snapshot Study.  MJA, 2016; 204 (3): 113.

Reid CM. Obituary.  Henry Krum, clinician, researcher and scientist.  MJA 2016; 205 (5): 201.  

Lonn E, Bosch J, LópezJaramillo P, Zhu Y,  Liu L, Pais P, Diaz R, Xavier D, Sliwa K, Dans A, Avezum A, Piegas LS, Keltai K, Keltai M, Chazova I, Peters RJG, Held C, Yusoff K, Lewis BS, Jansky P, Parkhomenko A, Khunti K, Toff WD, Reid CM, Varigos J, Leiter LA, Molina DI, McKelvie R, Pogue J, Wilkinson J, Jung H, Dagenais G, Yusuf S for the HOPE3 Investigators. Blood-Pressure Lowering in Intermediate- Risk Persons without Cardiovascular Disease.  New Engl J Med 2016; 374; 21: 2009 – 2020.

Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, LópezJaramillo PA, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJG, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P,  Khunti K, Toff WD, Reid CM, Varigos J, SanchezVallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, and E. Lonn, for the HOPE3 Investigators.  Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.  New Engl J Med 2016;274; 21: 2021-2031.  

Yusuf S, Lonn E, Pais P, Bosch J, LópezJaramillo P, Zhu Y, Xavier D, Avezum A, Leiter LA, Piegas LS, Parkhomenko A, Keltai M, Keltai K, Sliwa K, Chazova I, Peters RJG, Held C, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Accini JL, McKelvie R, Pogue J, Jung H, Liu L, Diaz R, Dans A, Dagenais G for the HOPE3 Investigators.  Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease. New Engl J Med, 2016, 2031 - 2043:  

Boffa U, McGrady M, Reid CM, Shiel L, Wolfe R, Liew D, Campbell DJ, Stewart S, Krum H. SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF): early detection of chronic heart failure in the workplace. Australian Health Review 2016,

Sahle BW, Owen AJ, Mutowo MP, Krum H and Reid CM. Prevalence of heart failure in Australia: a systematic review.  BMC Cardiovascular Disorders 2016, 16: 32: DOI: 10.1186/s 12872 -016-0208-4.

Yudi MB, Clark DJ, Farouque O, Eccleston D, Andrianopoulos N, Duffy SJ, Brennan A, Lefkovits J, Yip T, Oqueli E, Reid CM, Ajani AE on behalf of the Melbourne Interventional Group.  Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention.  Intern Medical J, 2016; 46(5): 559-565  

Chowdhury EK, Jennings G, Dewar E, Wing LM, and Reid CM; Second Australian National Blood Pressure Study Management Committee. Predictive performance of echocardiographic parameters for cardiovascular events among elderly treated hypertensive patients. Am J Hypertens, 2016;   

Hunter RA, Moore J, Heriot A, Platell C, Byrne C, Chapuis P, Doudle M, McMurrick P, Murphy E, Thompson-Fawcett M, Brennan A, Reid CM, O’Regan M.  Evolution of the Bi-National Colorectal Cancer Audit: history, governance and future directions.  ANZ J Surg, 2016; 86(6) :431–432

Teloken PE, Spilsbury K, Platell C, Heriot A, Byrne C, Chapuis P, Doudle M, McMurrick P, Murphy E, Thompson-Fawcett M, Brennan A, Reid CM, O’Regan M, Hunter A. Analysis of mortality in colorectal surgery in the Bi-National Colorectal Cancer Audit ANZ J Surg, 2016; 86 :454–458

Russell EA, Baker RA, Bennetts JS, Brown A, Reid CM, Tam R, Tran L, Walsh WF, Maguire GP. Case load and valve surgery outcome in Australia. International Journal of Cardiology, 2016; 221: 144–151.  

Berk M, Woods RL, Nelson MR, Shah RC, Reid CM, Storey E, Fitzgerald S, Lockery JE, Wolfe R, Mohebbi M, Murray AM, Kirpach B, Grimm R and McNeil JJ, on behalf of the ASPREE investigators.  ASPREE-D; Aspirin for the prevention of depression in the elderly. International Psychogeriatrics, 2016.

Iyngkaran P, Liew D, McDonald P, Thomas MC, Reid C, Chew DP, Hare DL. Phase 4 Studies in Heart Failure - What is Done and What is Needed? Current Cardiology Reviews, 2016; 12: 000-000 

Yudi MB, Ajani AE, Andrianopoulos N, Duffy SJ, Farouque O, Gurvitch R, Lefkovits J, Freeman M, Brennan A, Clark DJ, Reid CM, Eccleston D, on behalf of the Melbourne Interventional Group.  Early versus Delayed Percutaneous Coronary Intervention in Patients with Non-ST Elevation Acute Coronary Syndromes Coronary Artery Disease 2016, 27(5); 344-349

Coulson TG, Bailey M, Reid CM, Tran L, Mullany DV, Parker J, Hicks P, Pilcher D.  Acute Risk Change (ARC) identifies outlier institutions in perioperative cardiac surgical care when the standardized mortality ratio cannot. Brit J Anaesthesia 2016, 117 (2):164-171

Coulson TG, Mullany DV, Reid CM, Bailey M, Pilcher D. Measuring the quality of perioperative care in cardiac surgery.  Eur Heart J – Quality of care 2016: DOI:

Dhurandhar V, Parikh R, Saxena A, Vallely MP, Wilson MK, Black DA, Tran L, Reid CM, Bannon PG. Early and late outcomes following valve sparing aortic root reconstruction: The ANZSCTS database. Heart Lung Circulation.  2016 Dec;25; 505-511

Sahle BW, Owen AJ, Wing LMH, Nelson MR, Jennings GLR, and Reid CM on behalf of the Second Australian National Blood Pressure Study Management Committee. Prediction of 10-year Risk of Incident Heart Failure in Elderly Hypertensive Population: The ANBP2 Study. Am J Hypertension, 2016; doi:10.1093/ajh/hpw119.  

Yudi MB, Ramchand J, Farouque O, Andrianopoulos N, Chan W, Duffy SJ, Lefkovits J, Brennan A, Spencer R, Fernando D, Hiew C, Freeman M, Reid CM, Ajani AE, Clark DJ on behalf of the Melbourne Interventional Group.  Impact of door-to-balloon time on long-term mortality in high- and low-risk patients with ST-elevation myocardial infarction. International Journal of Cardiology, 2016; 224: 72–78.  

Hussain MA, Mamun AA, Reid CM, Huxley RR. Prevalence, Awareness, Treatment and Control of Hypertension in Indonesian Adults: Findings from the Indonesia Family Life Survey (IFLS).  PLOS One, 2016; Aug 24;

Yudi M, Clark DJ, Tsang D, Jelinek M, Nassis A, Joshi S, Amerena J, Dart A, Reid C, Kalten K, Farouque O.  SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes [SMART-REHAB Trial]: A Randomized Controlled Trial Protocol.
BMC Cardiovascular Disorders, 2016; 16: 170.  DOI 10.1186/s12872-016-0356-6

Hayek A; Joshi R; Usherwood T, Webster R, Kaur B, Saini B, Armour C, Krass I, Laba T-L, Reid C, Shiel L, Hespe C, Hersh F, Jan S, Lo S, Peiris D, Rodgers A, Patel A. An integrated general practice and pharmacy-based intervention to promote use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trial. Implementation Science, 2016; 11: 129.  DOI: 10.1186/s13012-016-0488-1

ul Haq M, Tsay IM, Dinh DT, Brennan A, Clark D, Cox N, Harper R, Nadurata V, Andrianopoulos N, Reid CM, Duffy SJ, Lefkovits J, van Gaal WJ. Prevalence and Outcomes of Trans-radial Access for Percutaneous Coronary Intervention in Contemporary Practice.  Inter J Cardiology, 2016; 221:264-268

Dhurandhar V, Parikh R, Saxena A, Vallely MP, Wilson MK, Black DA, Tran L, Reid CM, Bannon PG. The aortic root replacement procedure: 12 year experience from the ANZSCTS database. Heart Lung Circulation, 2016; 25: 1245-1251.

Chin KL, Skiba M, Tonkin A, Reid CM, Liew D, Krum H, Hopper I. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.  Heart Failure Reviews, 2016; 21(6): 675-697

Bergin K, Moore E, McQuilten Z, Wood E, Augustson B, Blacklock H, Ho J, Horvath N, King T, McNeil J, Mollee P, Quach H, Reid CM, Rosengarten B, Walker P, Spencer A. Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry. BMC Medical Research Methodology, 2016; 16:151

Calderone A, Stevens W, Prior D, Nandurkar H, Gabbay E, Proudman SM, Williams T, Celermajer D, Sahhar J, Wong PKK, Thakkar V, Dwyer N, Wrobel J, Chin W, Liew D, Staples M, Buchbinder R, Nikpour M. A multi-centre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol. BMJ Open. 2016

Gursanscky J, Young J, Griffet K, Liew D, Smallwood D. The benefit of targeted, pharmacist-led education for junior doctors in reducing prescription writing errors – a controlled trial. J Pharm Practice Res. 2016

Venalaien O, Bell S, Kirkpatrick K, Liew D, Ilomaki J. Adverse drug reactions associated with cholinesterase inhibitors - sequence symmetry analyses using prescription claims data. J Am Med Dir Assoc. 2016

Furler JS, O'Neal DN, Speight J, Manski-Nankervis JA, Gorelik A, Holmes-Truscott E, Ginnivan L, Young D, Best J, Patterson E, Liew D, Segal L, May CR, Blackberry ID. Supporting insulin initiation in type 2 diabetes in primary care: Results of the Stepping Up pragmatic cluster randomised controlled clinical trial. BMJ. 2016

Tropea J, LoGiudice D, Roberts C, Liew D, Brand C. Caring for people with dementia in hospital: findings from a survey to identify barriers and facilitators to implementing best practice dementia care. Int Psychogeriatr. 2016

Hua Y, Wang I, Liu B, Kelly DJ, Reid C, Liew D, Zhou Y, Wang BH. Angiotensin receptor neprilysin inhibitor LCZ696 (Entresto): Pharmacology, pharmacokinetics and clinical development. Future Cardiol. 2016

Ademi Z, Pasupathi K, Liew D. Clinical and cost effectiveness of apixaban compared to aspirin in patients with atrial fibrillation: an Australian perspective. Appl Health Econ Health Policy. 2016 Oct 4

Rixon S, Braaf S, Williams A, Liew D, Manias E. The functions and roles of questioning during nursing handovers in specialty settings: An ethnographic study. Contemp Nurse. 2016; 7:1-33.

Ademi Z, Pasupathi K, Liew D. Cost-effectiveness of eplerenone compared to usual care in patients with chronic heart failure and NYHA Class II symptoms, an Australian perspective. Medicine (Baltimore). 2016 May;95(18):e3531. doi: 10.1097/MD.0000000000003531.

Wright EK, Kamm MA, Dr Cruz P, Hamilton AL, Ritchie KJ, Bell SJ, Brown SJ, Connell WR, Desmond PV, Liew D. Cost-effectiveness of Crohn's disease post-operative care. World J Gastroenterol. 2016 Apr 14;22(14):3860-8. doi: 10.3748/wjg.v22.i14.3860.

Chen Z, Liew D, Kwan P. Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment. Neurology. 2016; 86:1086-94.

Kazankov K, Rode A, Simonsen K, Villadsen GE, Nicoll A, Møller HJ, Lim L, Angus P, Kronborg I, Arachchi N, Gorelik A, Liew D, Vilstrup H, Frystyk J, Grønbæk H. Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma. Scand J Clin Lab Invest. 2016; 76: 64-73.

Tully PA, Gogos AJ, Love C, Liew D, Drummond KJ, Morokoff AP. Reoperation for Recurrent Glioblastoma is Not Associated With Survival Benefit. Neurosurgery. 2016; 79: 678-89.

Thapa B, Walkeiwicz M, Murone C, Asadi K, Deb S, Barnett SA, Knight S, Mitchell P, Liew D, Watkins N, John T. Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma. Pathology. 2016 Oct 22. pii: S0031-3025(16)40292-8. doi: 10.1016/j.pathol.2016.08.003.

Brotchie J, Chapple P, Came N, Liew D, Juneja S. Reference ranges of peripheral blood lymphoid subsets by 10-colour flow cytometry based on 69 healthy adults from Australia. Pathology. 2016 Oct;48(6):631-4. doi: 10.1016/j.pathol.2016.06.005. Epub 2016 Sep 2.

Huynh J, Lu T, Liew D, Doery J, Tudball R, Jona M, Bhamjee R, Rodda CP. Vitamin D in newborns. A randomised controlled trial comparing daily and single oral bolus vitamin D in infants. J Paediatr Child Health. 2016. doi:10.1111/jpc.13338

Varney J, Liew D, Weiland T, Inder W, Jelinek G. The cost-effectiveness of hospital-based telephone coaching for people with type 2 diabetes: a 10 year modelling analysis. BMC Health Serv Res. 2016; 16:521.

Welton RE, Williams DJ, Liew D. Injury trends from envenoming in Australia, 2000-2013. Intern Med J. 2016 Oct 17. doi: 10.1111/imj.13297

Chen Z, Liew D, Kwan P. Excess Mortality and Hospitalized Morbidity in Newly Treated Epilepsy Patients. Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000002984.

Walker KJ, Dunlop W, Liew D, Staples MP, Johnson M, Ben-Meir M, Gordon-Rodda H, Turner I, Phillips D.  An economic evaluation of the costs of training a medical scribe to work in Emergency Medicine. Emerg Med J.  doi:10.1136/emermed-2016- 205934

Tropea J, LoGiudice D, Liew D, Gorelik A, Brand C. Poorer outcomes and greater healthcare costs for hospitalised older people with dementia and delirium: a retrospective cohort study. Int J Geriatr Psychiatry. 2016 Apr 25. doi: 10.1002/gps.4491.

Wright EK, Kamm MA, DeCruz P, Hamilton AL, Ritchie K, Keenan J, Leach S, Burgess L, Aitchison A, Gorelik A, Liew D, Day AS, Gearry RB. Comparison of Fecal Inflammatory Markers in Crohn’s Disease. Inflamm Bowel Dis. 2016 Jan 27